<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03978260</url>
  </required_header>
  <id_info>
    <org_study_id>E35/19</org_study_id>
    <nct_id>NCT03978260</nct_id>
  </id_info>
  <brief_title>Preoperative Anaemia prevaLence In surgiCal patiEnts</brief_title>
  <acronym>ALICE</acronym>
  <official_title>Preoperative Anaemia Prevalence in Surgical Patients- A Prospective, International, Multicentre Observational Study (ALICE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitari del Mar de Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Marsden NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Hietzing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Frankfurt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Auckland City Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative anaemia is common in surgery, with a prevalence between 10 and 50 %, and is an&#xD;
      independent risk factor for morbidity and mortality.&#xD;
&#xD;
      Anaemia is mostly the result of an inadequate erythropoiesis due to iron deficiency, lack of&#xD;
      vitamin B12 or folate, and bone marrow diseases. Among the elderly, renal disease and chronic&#xD;
      inflammation account for approximately one-third of all anaemia incidences. The aim of this&#xD;
      study is to provide detailed data about the prevalence of preoperative deficiencies in iron,&#xD;
      vitamin B12 and/or folate and the presence of underlying renal or chronic diseases in&#xD;
      patients undergoing major surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preoperative anaemia is common in surgery, with a prevalence between 10 and 50 %, and is an&#xD;
      independent risk factor for morbidity and mortality. Due to the potential risk of additional&#xD;
      blood loss, anaemia represents a serious disease condition within the surgical field.&#xD;
      Especially patients undergoing major elective surgery are at risk of substantial blood loss.&#xD;
      Anaemia is mostly the result of an inadequate erythropoiesis due to iron deficiency, lack of&#xD;
      vitamin B12 or folate, and bone marrow diseases. Among the elderly, renal disease and chronic&#xD;
      inflammation account for approximately one-third of all anaemia incidences. The aim of this&#xD;
      study is to provide detailed data about the prevalence of preoperative deficiencies in iron,&#xD;
      vitamin B12 and/or folate and the presence of underlying renal or chronic diseases in&#xD;
      patients undergoing major surgery. Results will facilitate design of supplementation&#xD;
      strategies to improve haemoglobin level before surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 30, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of preoperative anaemia</measure>
    <time_frame>prior surgery</time_frame>
    <description>Hemoglobin level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with red blood cell transfusion</measure>
    <time_frame>30 day</time_frame>
    <description>Amount of transfused units per patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patient with revision</measure>
    <time_frame>90 day</time_frame>
    <description>Number of patients with Revision after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with mortality</measure>
    <time_frame>90 day</time_frame>
    <description>in-hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-admission</measure>
    <time_frame>up to 90 days after discharge</time_frame>
    <description>Re-admission rates up to 90 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital and ICU length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>Time from Admission till discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hospital-acquired anaemia</measure>
    <time_frame>30 days</time_frame>
    <description>Hemoglobin level</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Anemia</condition>
  <condition>Iron-deficiency</condition>
  <condition>Folic Acid Deficiency</condition>
  <condition>Vitamin B 12 Deficiency</condition>
  <condition>Anaemia of Renal Disease</condition>
  <condition>Anemia of Chronic Inflammation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Major surgical patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
          -  Written informed consent prior to study participating according to the national law&#xD;
             requirements&#xD;
&#xD;
          -  Patients undergoing major surgery&#xD;
&#xD;
          -  Expected hospital stay with a minimum of 24 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preoperative autologous blood donation&#xD;
&#xD;
          -  Patients with expected re-surgery within the planned 7-day recruitment period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe University Hospital</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hesse</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Meybohm, Prof. Dr.</last_name>
      <phone>+49 (0) 69 630187461</phone>
      <email>patrick.meybohm@kgu.de</email>
    </contact>
    <contact_backup>
      <last_name>Suma Choorapoikayil, Dr.</last_name>
      <phone>+49 (0) 69 630183169</phone>
      <email>suma.choorapoikayil@kgu.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 23, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2019</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Patrick Meybohm, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Anemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Vitamin B 12 Deficiency</mesh_term>
    <mesh_term>Folic Acid Deficiency</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

